This product is used to cause the body to increase production of HGH. So instead of injecting the HGH directly, you inject the catalyst that causes the body to produce it. That results in a much more stable level of HGH, instead of levels shooting up for a couple hours after injecting HGH directly.
I doubt that the FDA would approve HGH or, in this case, an HGH catalyst, as a "lifestyle" drug. Otherwise, HGH producers would have gone that route years ago. It's well documented that HGH reduces body fat when accompanied with exercise. Therefore, the only legitimate market for this drug would be to target something like HIV lipo. Remember the manufacturers of Serostim took the same route to get rapid approval by targeting HIV patients, in that case, to gain muscle mass.
There is a difference between HIV lipo fat and what is known as adipose fat. The lipo fat is internal, around the organs, and hard. It is inoperable (cannot be removed by liposuction without damaging organs). However, the point is that this class of drugs is better than injecting HGH directly. If HGH is known to work on adipose fat, this drug would work better.FYI, another company (AEZS) has an HGH catalyst (AEZS-130) that should be on the market in a year. The route they are taking to get FDA approval is to target the drug as a diagnostic test. That should provide a means to get FDA approval. They have also started a trial (or will be) to use the drug to help cancer patients gain muscle mass (note this is nearly the same path taken for Egrifta).
I'm expecting that eventually lookalikes will eventually hit the black market and could replace HGH altogether as a body building supplement.
